Julia Schaefer

Columbia University Irving Medical Center

Papers

1

Total Citations

77

H-Index

1

About

Dr. Julia Schaefer is a leading expert in radiation biodosimetry, with a primary focus on developing and refining high-throughput methods for assessing DNA damage in human cells. Her most significant contribution centers on the γ-H2AX assay, a sensitive biomarker for detecting DNA double-strand breaks (DSBs) following radiation exposure. In her highly cited 2010 work, "Adapting the γ-H2AX Assay for Automated Processing in Human Lymphocytes. 1. Technological Aspects" (77 citations), Schaefer pioneered the automation of this immunofluorescence-based technique, transforming it from a labor-intensive manual process into a scalable, rapid screening tool. This innovation is critical for triaging large populations after a radiological incident, enabling faster and more accurate dose estimates. By demonstrating that H2AX phosphorylation remains highly linear with radiation dose, her work established the assay as a gold standard for modern biodosimetry. Schaefer’s research bridges the gap between laboratory precision and real-world emergency response, making her a pivotal figure in radiation biology and public health preparedness.

Research Focus

Key Achievements

1
H-Index
1
Papers
77
Total Citations
77
Avg Citations/Paper
🏆 Most Cited Paper
Adapting the γ-H2AX Assay for Automated Processing in Human Lymphocytes. 1. Technological Aspects
77 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Columbia University Irving Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago